Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-817-4 | CAS number: 84434-18-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988-03-17 to 1988-04-21
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was conducted to GLP. Limited details on test substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- N,2-dimethyl-N-phenylbutyramide
- EC Number:
- 282-817-4
- EC Name:
- N,2-dimethyl-N-phenylbutyramide
- Cas Number:
- 84434-18-4
- Molecular formula:
- C12H17NO
- IUPAC Name:
- N,2-dimethyl-N-phenylbutanamide
- Reference substance name:
- Unknown impurities
- Molecular formula:
- Unknown
- IUPAC Name:
- Unknown impurities
- Test material form:
- liquid
Constituent 1
impurity 1
- Specific details on test material used for the study:
- Test substance name: Gardamide
Purity: 100%
Colour: Clear liquid
Storage: Ambient temperature in the dark
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Equal numbers of male and female CD rats [Crl: CD(SD)BR] were obtained from Charles River U.K. Ltd., Margate, Kent. They were in a weight range of 106 to 152 g prior to dosing {Day 1} and approximately four to six weeks of age. All the rats were acclimated to the experimental environment for a period of 8 days prior to the stat of the study.
The rats were allocated to cages within the treatment groups. They were housed in groups by sex in metal cages with wire mesh floors. A standard laboratory rodent diet (Labsure LAD 1) and water were provided ad libitum. The batch of diet used for the study was analysed for certain chemical and microbiological contaminants. Access to food only was prevented overnight prior to and approximately four hours after dosing.
Results of routine chemical examination of water at source (Grafham Final Water) as conducted by the Anglian Water Authority, are made available to Huntingdon Research Centre.
The mean daily minimum and maximum temperature of the animal room were 22 °C and 24 °C respectively and the mean daily relative humidity value was 50%. The rate of air exchange was maintained at approximately 15 air changes/hour. Lighting was controlled by means of a time switch to provide 12 hours artificial light in each 24 hour period.
Each animal was identified by cage number and ear punching.
Each cage was idenitified by a colour label displaying the dose level, study schedule number and the initials of the Study Director.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 5.06 mL/kg. The test material was administered at dose volumes of 2.03 and 5.06 mL/kg.
DOSAGE PREPARATION: The test material was administered as supplied (specific gravity 0.99). - Doses:
- 2000 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 3 animals per sex per dose
- Control animals:
- no
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 - 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female rat was found dead three hours after oral administration of Gardamide 2.0 g/kg. Four rats died after treatment at 5.0 g/kg. These deaths occured within two hours of dosing or, in one case, on Day 2.
Slight vascular congestion and moderate congestion of the glandular zone of the stomach were apparent in the female rat found dead after treatment at 2.0 g/kg. Autopsy of other rats that died revealed no macroscopic abnormalities.
Bodywight losses (<10 g) were recorded for all rats that died. - Clinical signs:
- Pilo-erection and increased salivation were observed in all the rats within five minutes of dosing. Other clinical signs first apparent within two hours of doing were:
- abnormal body carriage (hunched posture), abnormal gait (waddling), descreased respiratory rate, ptsosis and prostration amongst rats treated at both dose levels
- lethargy and pallor of the extremities amongst rats dosed at the higher dose level
- body tremors in signle male and female rats treated at 2.0 g/kg
- twitching amongst rats of both sexes dosed at 5.0 g/kg.
Lethargy and pallor of the extremities were observed on Day 2 in one male dosed at the lower dose level. There were no other signs of reaction to treatment. Recovery of surviving rats, as judged by external appearance and behavious, was generally advanced by Day 2 and cpmplete by Day 3 or 4 (2.0 g/kg) or Day 7 (5.0 g/kg). - Body weight:
- Low body weight gains during the first week of the study were recorded for all surviving rats.
All rats achieved anticipated body weight gains between Days 8 and 15. - Gross pathology:
- Slight vascular congestion and moderate congestion of the glandular zone of the stomach were apparent in the female rat found dead after treatment at 2000 mg/kg. Autopsy of other rats that died revealed no macroscopic abnormalities.
All other terminal autopsy findings were normal.
Any other information on results incl. tables
Table 1: Individual and Group Mean Body Weights
Sex |
Dose (mg/kg) |
Body weight (g) |
|||
Day 1 |
Day 8 |
Day 15 |
Death |
||
Male |
2000 |
142 152 136 |
203 220 180 |
252 274 238 |
- - - |
Mean |
143 |
201 |
255 |
- |
|
5000 |
124 142 133 |
- 200 - |
- 274 - |
123 - 123 |
|
Mean |
133 |
- |
- |
- |
|
Female |
2000 |
131 106 122 |
- 138 165 |
- 160 190 |
128 - - |
Mean |
120 |
152 |
175 |
- |
|
5000 |
128 127 109 |
- 152 - |
- 199 - |
127 - 103 |
|
Mean |
121 |
- |
- |
- |
Table 2: Clinical Signs and Severity
Sign |
No. of Rats in Group Showing Signs |
|||
Dose (mg/kg) |
||||
2000 |
5000 |
|||
Male |
Female |
Male |
Female |
|
Pilo-erection |
3 |
3 |
3 |
3 |
Hunched posture |
3 |
2 |
3 |
3 |
Waddling |
3 |
2 |
1 |
2 |
Lethargy |
1 |
0 |
1 |
2 |
Decreased respiratory rate |
1 |
1 |
3 |
3 |
Ptosis |
1 |
1 |
3 |
3 |
Pallor of extremities |
1 |
0 |
3 |
3 |
Body tremors |
1 |
1 |
0 |
0 |
Prostrate |
1 |
1 |
3 |
2 |
Twitching |
0 |
0 |
3 |
2 |
Increased salivation |
3 |
3 |
3 |
3 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the acute median lethal oral dose of the test material to rats was found to be between 2000 and 5000 mg/kg bodyweight.
- Executive summary:
The acute oral toxicity of the test material was investigated in a study which was conducted under GLP conditions using methodology that was equivalent to the standardised guideline OECD 401.
During the study, groups of 3 male and female Crl: CD (SD) Br rats received a single dose of undiluted test material, by gavage, at dose levels of 2000 and 5000 mg/kg. Animals were observed for 14 days for mortality and toxic signs. Body weights were monitored. At the end of the observation period, surviving rats were euthanised and subjected to a macroscopic post mortem investigation.
One female rat was found dead three hours after oral administration of the test material at 2000 mg/kg. Four rats died after treatment at 5000 mg/kg. Pilo-erection and increased salivation were observed in all rats within five minutes of dosing. Other clinical signs included abnormal body carriage (hunched posture), abnormal gait (waddling), decreased respiratory rate, ptosis and prostration, lethargy and pallor of the extremities, body tremors and twitching.
Recovery of surviving rats, as judged by external appearance and behaviour, was generally advanced by Day 2 and complete by Days 3 or 4 (2000 mg/kg) or Day 7 (5000 mg/kg).
Under the conditions of this study, the acute median lethal oral dose of the test material to rats was found to be between 2000 (i.e. >2000 mg/kg) and 5000 mg/kg bodyweight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.